We study the perceived value derived from data sharing activities by the representatives of a Nordic pharmaceutical company in the introduction of the European Medicines Verification System (EMVS). The system is an end-to-end verification protocol that would potentially enable the pharmaceutical companies to access the sales-point data from within the system, while maintaining the control of their own data. The benefits of the system are most notably in developing data sharing with the wholesalers and end-customers. Development of data sharing practices might enable more transparent logistics, and more targeted services and products.
Studies in Health Technology and Informatics, vol. 272. pp. 276 – 279. IOS Press Ebooks.
Arkadiankatu 23 B
00100 HELSINKI
Vaihde ja vastaanotto avoinna arkisin klo 9–15:30.
+358 (09) 609 900